This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Spironolactone in female pattern hair loss (FPHL)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • spironolactone is an aldosterone antagonist used in the treatment of hypertension and has also been used in the treatment of FPHL
    • spironolactone also possesses antiandrogenic properties, acting as an androgen receptor antagonist and reducing the levels of cytochrome P450-dependent enzymes 17beta-hydroxylase and desmolase, which are both required for androgen synthesis
    • spironolactone has been shown to be safe and effective in the treatment of female pattern hair loss (FPHL) in adults

Reference:

  • 1. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br. J. Dermatol. 2005; 152: 466-73.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.